Concepedia

Combination Checkpoint Therapy

Combination Checkpoint Therapy is a therapeutic strategy in oncology that involves the concurrent use of two or more immune checkpoint inhibitors to enhance antitumor immune responses by targeting non-redundant inhibitory pathways within the immune system.

550

Publications

60.1K

Citations

5.3K

Authors

1.5K

Institutions

Publications per year

2017–2026

489

Parents

Publications

550

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text

, , +17

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.4K citations · Full text

, , +17

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2019 · 3.7K citations · Full text

, , +14

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

Michael A. Postow, Jason Chesney, Anna C. Pavlick et al. · New England Journal of Medicine · 2015 · 2.8K citations · Full text

, , +17

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

F. Stephen Hodi, Vanna Chiarion‐Sileni, René González et al. · The Lancet Oncology · 2018 · 1.4K citations

, , +16

1–5 of 550

Authors

5.3K

  1. FS
    F. Stephen Hodi

    Dana-Farber Cancer Institute, United States

    29 publications · 26.1K citations

    26

    h-index

  2. JD
    Jedd D. Wolchok

    Memorial Sloan Kettering Cancer Center, United States

    24 publications · 24.9K citations

    23

    h-index

  3. JL
    James Larkin

    Royal Marsden Hospital, United Kingdom

    21 publications · 21.2K citations

    19

    h-index

  4. DS
    Dirk Schadendorf

    Heidelberg University, Germany

    19 publications · 21.1K citations

    17

    h-index

  5. RD
    Reinhard Dummer

    University Hospital of Zurich, Switzerland

    16 publications · 20.2K citations

    16

    h-index

1–5 of 5.3K

Institutions

1.5K

  1. Memorial Sloan Kettering Cancer Center

    New York, United States

    44 h-index

    296 publications

    128.3K citations

  2. Dana-Farber Cancer Institute

    Boston, United States

    40 h-index

    180 publications

    46K citations

  3. Bristol-Myers Squibb (United States)

    New York, United States

    35 h-index

    144 publications

    81.1K citations

  4. The University of Texas MD Anderson Cancer Center

    Houston, United States

    32 h-index

    297 publications

    18.1K citations

  5. Cornell University

    Ithaca, United States

    26 h-index

    180 publications

    303.9K citations

  6. Moffitt Cancer Center

    Tampa, United States

    22 h-index

    77 publications

    7.8K citations

  7. Princess Margaret Cancer Centre

    Toronto, Canada

    22 h-index

    37 publications

    15.7K citations

  8. Institut Gustave Roussy

    Villejuif, France

    22 h-index

    32 publications

    6K citations

1–8 of 1.5K

Venues

  1. Journal of Clinical Oncology

    128 publications · 9.4K citations

    44

    h-index

  2. Journal for ImmunoTherapy of Cancer

    JITC · 37 publications · 2.6K citations

    30

    h-index

  3. Clinical Cancer Research

    25 publications · 2K citations

    25

    h-index

  4. Frontiers in Oncology

    16 publications · 545 citations

    14

    h-index

  5. Cancers

    13 publications · 417 citations

    13

    h-index

1–5